Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.030
-0.050 (-1.62%)
Jun 9, 2025, 10:29 AM - Market open
Eledon Pharmaceuticals Employees
Eledon Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 11 or 55.00% compared to the previous year.
Employees
31
Change (1Y)
11
Growth (1Y)
55.00%
Revenue / Employee
n/a
Profits / Employee
-$614,452
Market Cap
181.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ELDN News
- 25 days ago - Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 weeks ago - Undercovered Dozen: Gevo, Eledon, Dorian, Iridium + - Seeking Alpha
- 5 weeks ago - Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet - Seeking Alpha
- 2 months ago - Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human - GlobeNewsWire
- 4 months ago - Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 4 months ago - Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business - Seeking Alpha